SBIR/STTR Research Award

THE FETUS AS A PATIENT IS RELATIVELY INACCESSIBLE TO THE PHYSICIAN AND THUS PRESENTS GENUINE PROBLEMS IN MONITORING ITS WELL-BEING.

Award identifier 209d0ec1963130bb3f4375a6ada7fe62d08d8c883bd88ad49e59a0956f0c34f9Awarding agency Department of Health and Human Services

Award amount

$44,643

Program and phase

SBIR · Phase I

Award year

1985

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
Not reported
Recipient company
Procons Laboratories, Inc.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

THE FETUS AS A PATIENT IS RELATIVELY INACCESSIBLE TO THE PHYSICIAN AND THUS PRESENTS GENUINE PROBLEMS IN MONITORING ITS WELL-BEING. THE MAJORITY OF INTRAPARTUM ENDOCRINE ASSESSMENT OF THE COMPLEX MATERNAL-FETAL-PLACENTAL UNIT IS ONE APPROACH TO EARLY RECOGNITION OF FETAL DISTRESS. STEROID HORMONES OFFER SIGNIFICANT ADVANTAGE IN THIS REGARD, SINCE BIOSYNTHESIS OF ESTROGENS, PARTICULARY ESTRIOL (E3), INVOLVES FETAL ORGANS SUCH AS LIVER AND ADRENAL AS WELL AS PLACENTA AND MATERNAL LIVER. ESTETROL (E4), IS ANOTHER STEROID PRODUCED BY FETAL LIVER AND HAS NO CIRCADIAN RHYTHM. SERUM UNCONJUGATED ESTRIOL (E3) ASSAYS ARE WIDELY UTILIZED DURING THE THIRD TRIMESTER OF COMPLICATED PREGNANCY. HOWEVER, THE CLINICAL USEFULNESS OF SUCH ASSAYS IS DEBATABLE. DAILY SERUM E3 MEASUREMENTS ARE REQUIRED FOR PREDICTABLE RESULTS. IN ROUTINE CLINICAL PRACTICE, MATERNAL BLOOD SAMPLES ARE DIFFICULT TO COLLECT MORE THAN ONCE OR TWICE A WEEK. WEEKLY OR BIWEEKLY RESULTS ARE DISAPPOINTING, PARTICULARLY IN PROBLEM PREGNANCIES. SALIVA OFFERS AN ALTERNATIVE SOURCE FOR DAILY ASSESSMENT OF E3. KUNDU ET AL. HAVE ALREADY SHOWN ITS USEFULNESS BY RADIOIMMUNOASSAY (RIA) OF E3 IN SALIVA. ALTHOUGH E3 PROVIDED THE BASIS FOR ASSESSMENT OF PREGNANCY STATUS, DETERMINATION OF E4 LEVEL (A PRODUCT OF FETAL LIVER) WILL BE A PARTICULARLY SENSITIVE AND RELIABLE INDICATOR OF FETAL WELL-BEING. IT IS ALSO ASSAYED BY RIA IN A FEW LABORATORIES. HOWEVER, RIA IS A SOPHISTICATED PROCEDURE REQUIRING SPECIAL REAGENTS, RADIOACTIVE LIGANDS AND SPECTROMETER FOR RADIOACTIVITY DETERMINATION. THIS ASSAY IS EXPENSIVE AND LABOR-INTENSIVE. THE PRESENT PROPOSAL AIMS TO 1. DEVELOP SPECIFIC MONOCLONAL AND POLYCLONAL ANTIBODIES TO E3 AND E4 AND 2. PREPARE SPECIFIC ANTIBODY REAGENTS FOR NONISOTOPIC IMMUNOASSAY KITS FOR USE AT HOME OR IN HOSPITALS. THESE SPECIFIC AND HIGHLY SENSITIVE ASSAYS WILL BE SIMPLE AND RELIABLE. THEY WILL PROVIDE OBSTETRICIANS WITH TOOLS TO MONITOR THE FUNCTIONAL STATUS OF FETAL LIVER AND ADRENAL ON A ROUTINE BASIS.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.